Apeloa Scientific Advisory Board established in December 2022, abbreviated as "ASAB". The ASAB is dedicated to providing strategic direction and planning advice for the company, participating in the initiation and evaluation of major projects, and the recruitment and development of key talents. It offers recommendations on the adoption and application of advanced technologies, enhancing the professionalism and scientific rigor of Apeloa's strategic decision-making. This will propel Apeloa to the forefront of biomedical manufacturing technology both domestically and internationally, helping it to become a leading technology-driven pharmaceutical manufacturing company in China.
The inaugural ASAB is composed of five renowned experts in the field of biomedicine, specializing in areas such as organic chemical synthesis, synthetic biology, biomanufacturing engineering technology, chemical engineering and microfluidic technology, pharmaceutical engineering and processes, and drug molecular design and process development.
